Oncternal Therapeutics Inc (ONCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,032 | -25,140 | -2,294 | -6,579 | -5,801 |
| Accounts payable and accrued liabilities | -4,402 | -4,435 | -2,422 | 2,242 | 2,896 |
| Other Working Capital | -3,273 | -4,214 | -1,361 | -100 | 845 |
| Other Operating Activity | 24,006 | 23,917 | 2,444 | -2,980 | -3,086 |
| Operating Cash Flow | $-13,701 | $-9,872 | $-3,633 | $-7,417 | $-5,146 |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | -2,155 | -551 | -79 | N/A | N/A |
| Other Investing Activity | 18,292 | 18,292 | 0 | 0 | 0 |
| Investing Cash Flow | $16,137 | $17,741 | $-79 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 15 | 2 | 2 | 1 | N/A |
| Other Financing Activity | 0 | 0 | 0 | 17,873 | 1,100 |
| Financing Cash Flow | $15 | $2 | $2 | $17,874 | $1,100 |
| Beginning Cash Position | 20,645 | 20,645 | 20,645 | 10,188 | 10,188 |
| End Cash Position | 23,096 | 28,516 | 16,935 | 20,645 | 6,142 |
| Net Cash Flow | $2,451 | $7,871 | $-3,710 | $10,457 | $-4,046 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,701 | -9,872 | -3,633 | -7,417 | -5,146 |
| Free Cash Flow | -13,701 | -9,872 | -3,633 | -7,417 | -5,146 |